to the suggested rate, which is less than 1 leprosy case in 10,000
inhabitants. It was expected that, from this small number of patients in the population, the transmission would be extremely reduced, with gradual disappearance of the condition. 3 However, the predictions did not materialize. 3 What we see is that, despite all advances with a marked decrease in the prevalence rates (known registered cases), the incidence did not show significant differences, indicating that transmission was not significantly affected. 4, 5, 6 Among the core problems for the treatment and control of Hansen's disease are the need for a classification of the patients, The project was already finalized, demonstrating that the objectives are feasible and can be implemented in all endemic countries. 7, 8 The use of a single therapeutic regimen, without the need for classification through tests will certainly contribute to a better operationalization of the treatment for patients; however, we still have a long way ahead to reduce the transmission and the number of new patients, with unfortunately a high proportion of deformities.
In the Continuing Medical Education article of this edition we approach the different aspects related to Hansen's disease, including the details related to treatment regimens in the past few decades.
